The August 2007 sales numbers for foreign automakers Honda Motor Ltd. (NYSE: HMC), Toyota Motor Co. (NYSE: TM) and Nissan Motors (NYSE: NSANY) were up in the U.S., as all three boosted production output to meet increased demand in both the U.S. and Asia. According to the latest global figures, Toyota increased production 7.8% to 670,838 vehicles, while Honda bumped production 8.4% to 311,117 vehicles. Add Nissan's increase of 17% to 267,390 vehicles and you have a wallop of a production increase here.
Both Ford Motor Co. (NYSE: F) and Chrysler may have lost market share to this trio in September as well, possibly due to a growing number of buyers opting for more fuel-efficient vehicles. In many cases, the fuel-efficient offerings from all three Japanese automakers are perceived to be more readily available and more stylish compared to models from domestic automakers like Ford and Chrysler.
Indeed, increasing sales of fuel-efficient vehicles like the Toyota Corolla and Honda Accord are driving growth at both automakers. Japanese passenger car sales were up for the first time in 26 months in August, with higher sales of Honda's Fit compact and the CR-V small SUV leading the way. In addition, Honda says July shipments to the U.S. increase 44% due to record demand.
Are the domestic automakers really hurting due to high gas prices and the housing market slump, or are the Japanese-based competitors selling more cars and trucks to customers based on fuel economy alone? It's hard to say whether gas efficiency or better perceived reliability are reasons here, but based on the particular Japanese models selling like hotcakes, gas prices are at the forefront of many a car purchase decisions these days.
Last updated: February 13, 2012: 11:20 AM
Hot Stocks
Learn More About Ford Cars
Ford Brands:
DailyFinance Headlines
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- Diebold FY11 free cash flow exceeded guidance by more than $10M
- Applied Materials March volatility flat into Q1 and sales outlook
- Rumor: Dendreon active on speculation it canceled a conference presentation
- President Obama to discuss FY2013 budget proposal
- Diebold expects the same quarterly seasonality in FY12 as last years'
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

